Kong, Yanyan
Maschio, Cinzia A.
Shi, Xuefeng
Xie, Fang
Zuo, Chuantao
Konietzko, Uwe
Shi, Kuangyu
Rominger, Axel
Xiao, Jianfei
Huang, Qi
Nitsch, Roger M.
Guan, Yihui
Ni, Ruiqing http://orcid.org/0000-0002-0793-2113
Funding for this research was provided by:
Swiss Centre for Applied Human Toxicology (SCAHT-AP_22_01)
Neuroscience Center Zurich, University of Zurich
Helmut Horten Stiftung
National Natural Science Foundation of China (82272108, 81701732)
Natural Science Foundation of Shanghai Municipality (22ZR1409200)
Shanghai Science and Technology Innovation Action Plan Medical Innovation Research Project (23Y11903200)
University of Zurich
Article History
Received: 25 September 2023
Accepted: 6 March 2024
First Online: 19 March 2024
Declarations
:
: The PET imaging and experimental protocol were approved by the Institutional Animal Care and Ethics Committee of Fudan University and performed in accordance with the National Research Council’s Guide for the Care and Use of Laboratory Animals. All the experiments in Zurich were performed in accordance with the Swiss Federal Act on Animal Protection and were approved by the Cantonal Veterinary Office Zurich (ZH162/20).
: Not applicable.
: Not applicable.
: RMN is employee and shareholder of Neurimmune AG, Switzerland.The other authors declare no competing interests.